Related references
Note: Only part of the references are listed.Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Yu Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
Venissa Machado et al.
NEUROBIOLOGY OF DISEASE (2016)
In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease
Sherise L. Simms et al.
NEUROPHARMACOLOGY (2016)
Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease
Stefan Jean-Pierre Haas et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
Shane V. Hegarty et al.
NEURAL REGENERATION RESEARCH (2014)
The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
The hallmarks of Parkinson's disease
Paul M. A. Antony et al.
FEBS JOURNAL (2013)
GDF-15 prevents platelet integrin activation and thrombus formation
J. Rossaint et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
NAG-1/GDF15 Transgenic Mouse Has Less White Adipose Tissue and a Reduced Inflammatory Response
J. M. Kim et al.
MEDIATORS OF INFLAMMATION (2013)
Growth Differentiation Factor-15 Suppresses Maturation and Function of Dendritic Cells and Inhibits Tumor-Specific Immune Response
Zhizhong Zhou et al.
PLOS ONE (2013)
Growth Differentiation Factor-15 in the Early Diagnosis and Risk Stratification of Patients with Acute Chest Pain
Nora Schaub et al.
CLINICAL CHEMISTRY (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease (vol 2, e142, 2011)
C. Barcia et al.
CELL DEATH & DISEASE (2012)
Current advances in using neurotrophic factors to treat neurodegenerative disorders
April M. Weissmiller et al.
TRANSLATIONAL NEURODEGENERATION (2012)
Improved method for simultaneous isolation of proteins and nucleic acids
Soroth Chey et al.
ANALYTICAL BIOCHEMISTRY (2011)
Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis
Johanna Schneider et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism
Samuel N. Breit et al.
GROWTH FACTORS (2011)
Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis
Saskia C. A. de Jager et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
Tibor Kempf et al.
NATURE MEDICINE (2011)
Repairing the parkinsonian brain with neurotrophic factors
Liviu Aron et al.
TRENDS IN NEUROSCIENCES (2011)
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
Adrian P. Kells et al.
JOURNAL OF NEUROSCIENCE (2010)
Progressive Postnatal Motoneuron Loss in Mice Lacking GDF-15
Jens Strelau et al.
JOURNAL OF NEUROSCIENCE (2009)
Glial reactions in Parkinson's disease
Patrick L. McGeer et al.
MOVEMENT DISORDERS (2008)
Treatment of Parkinson's disease with trophic factors
Amie L. Peterson et al.
NEUROTHERAPEUTICS (2008)
RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals
Sebastian Kowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Endogenous transforming growth factor β1 suppresses inflammation and promotes survival in adult CNS
Milan Makwana et al.
JOURNAL OF NEUROSCIENCE (2007)
GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-β for its neuroprotective action
Andreas Schober et al.
NEUROBIOLOGY OF DISEASE (2007)
FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice
S Zechel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Neuroinflammatory processes in Parkinson's disease
EC Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2005)
Differential inflammatory activation of IL-6 (-/-) astrocytes
LM Bolin et al.
CYTOKINE (2005)
In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats
S Sarre et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
C Barcia et al.
GLIA (2004)
Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation
P Teismann et al.
CELL AND TISSUE RESEARCH (2004)
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP
A Schober
CELL AND TISSUE RESEARCH (2004)
Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain
TC Brionne et al.
NEURON (2003)
Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice
H Cardenas et al.
BRAIN RESEARCH (2003)
Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways
S Subramaniam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pathogenic role of glial cells in Parkinson's disease
P Teismann et al.
MOVEMENT DISORDERS (2003)
Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice
LM Bolin et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The role of glial cells in Parkinson's disease
M Vila et al.
CURRENT OPINION IN NEUROLOGY (2001)
Experimental models of Parkinson's disease
MF Beal
NATURE REVIEWS NEUROSCIENCE (2001)
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Neurochemical findings in the MPTP model of Parkinson's disease
N Schmidt et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2
C Knott et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Share Paper
